Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Dermatology and Therapy|January 6, 2026
Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International CohortJosé Miguel Alvarenga, Jensen Yeung, Vimal Prajapati, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitisTiago Torres, Mario Valenti, Anna Balato, et al.
Acta Dermato-Venereologica|October 28, 2020
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy|June 3, 2025
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort StudyTiago Torres, Jensen Yeung, Vimal H Prajapati, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Dermatology (Basel, Switzerland)|July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert PanelAnnamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
American Journal of Clinical Dermatology|August 17, 2022
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Journal of Clinical Medicine|January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe PsoriasisFrancesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Dermatology and Therapy|January 6, 2026
Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International CohortJosé Miguel Alvarenga, Jensen Yeung, Vimal Prajapati, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitisTiago Torres, Mario Valenti, Anna Balato, et al.
Acta Dermato-Venereologica|October 28, 2020
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy|June 3, 2025
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort StudyTiago Torres, Jensen Yeung, Vimal H Prajapati, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Dermatology (Basel, Switzerland)|July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert PanelAnnamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
American Journal of Clinical Dermatology|August 17, 2022
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Journal of Clinical Medicine|January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe PsoriasisFrancesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Pageof 20